Literature DB >> 21515406

Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.

Chie Kojima1, Baris Turkbey, Mikako Ogawa, Marcelino Bernardo, Celeste A S Regino, L Henry Bryant, Peter L Choyke, Kenji Kono, Hisataka Kobayashi.   

Abstract

Polyethylene glycol (PEG) surface modification can make nanomaterials highly hydrophilic, reducing their sequestration in the reticuloendothelial system. In this study, polyamidoamine (PAMAM) dendrimers bearing gadolinium (Gd) chelates were PEGylated with different PEG-chain lengths, and the effects on paramagnetic and pharmacokinetic properties were evaluated. Specifically, Gd chelate-bearing PAMAM dendrimers (generations 4 and 5; G4 and G5) were conjugated with two different PEG chains (2 kDa and 5 kDa; 2k and 5k). Long PEG chains (5k) on the smaller (G4) dendrimer resulted in reduced relaxivity compared to non-PEGylated dendrimers, whereas short PEG chains (2k) on a larger (G5) dendrimer produced relaxivities comparable to non-PEGylated G4 dendrimers. The relaxivity of all PEGylated or lysine-conjugated dendrimers increased at higher temperature, whereas that of intact G4 Gd-PAMAM dendrimer decreased. All PEGylated dendrimers had minimal liver and kidney uptake and remained in circulation for at least 1 hour. Thus, surface-PEGylated Gd-PAMAM dendrimers showed decreased plasma clearance and prolonged retention in the blood pool. Shorter PEG, higher generation conjugates led to higher relaxivity. FROM THE CLINICAL EDITOR: In this study, polyamidoamine dendrimers bearing gadolinium (Gd) chelates were PEGylated with different PEG-chain lengths, and the effects on paramagnetic and pharmacokinetic properties were evaluated.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515406      PMCID: PMC3159711          DOI: 10.1016/j.nano.2011.03.007

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  23 in total

1.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs.

Authors:  C Kojima; K Kono; K Maruyama; T Takagishi
Journal:  Bioconjug Chem       Date:  2000 Nov-Dec       Impact factor: 4.774

Review 2.  Dendrimers designed for functions: from physical, photophysical, and supramolecular properties to applications in sensing, catalysis, molecular electronics, photonics, and nanomedicine.

Authors:  Didier Astruc; Elodie Boisselier; Cátia Ornelas
Journal:  Chem Rev       Date:  2010-04-14       Impact factor: 60.622

Review 3.  Dendrimers in biomedical applications--reflections on the field.

Authors:  Sönke Svenson; Donald A Tomalia
Journal:  Adv Drug Deliv Rev       Date:  2005-11-21       Impact factor: 15.470

4.  Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).

Authors:  H Kobayashi; T Saga; S Kawamoto; N Sato; A Hiraga; T Ishimori; J Konishi; K Togashi; M W Brechbiel
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 5.  Dendrimers in oncology: an expanding horizon.

Authors:  Rakesh Kumar Tekade; Palanirajan Vijayaraj Kumar; Narendra Kumar Jain
Journal:  Chem Rev       Date:  2009-01       Impact factor: 60.622

6.  New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules.

Authors:  Mikako Ogawa; Celeste A S Regino; Bernardo Marcelino; Mark Williams; Nobuyuki Kosaka; L Henry Bryant; Peter L Choyke; Hisataka Kobayashi
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

7.  Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.

Authors:  Kido Nwe; L Henry Bryant; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2010-06-16       Impact factor: 4.774

8.  PAMAM dendrimeric conjugates with a Gd-DOTA phosphinate derivative and their adducts with polyaminoacids: the interplay of global motion, internal rotation, and fast water exchange.

Authors:  Jakub Rudovský; Mauro Botta; Petr Hermann; Kenneth I Hardcastle; Ivan Lukes; Silvio Aime
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

Review 9.  Dendrimer-based contrast agents for molecular imaging.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Curr Top Med Chem       Date:  2008       Impact factor: 3.295

10.  Physicochemical and MRI characterization of Gd3+-loaded polyamidoamine and hyperbranched dendrimers.

Authors:  Zoltán Jászberényi; Loïck Moriggi; Philipp Schmidt; Claudia Weidensteiner; Rainer Kneuer; André E Merbach; Lothar Helm; Eva Tóth
Journal:  J Biol Inorg Chem       Date:  2007-01-10       Impact factor: 3.862

View more
  16 in total

1.  Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis.

Authors:  Tuyen H Nguyen; Henry Bryant; Ari Shapsa; Hannah Street; Venkatesh Mani; Zahi A Fayad; Joseph A Frank; Sotirios Tsimikas; Karen C Briley-Saebo
Journal:  J Magn Reson Imaging       Date:  2014-03-10       Impact factor: 4.813

2.  Quantification of the plasma clearance kinetics of a gadolinium-based contrast agent by photoinduced triplet harvesting.

Authors:  Stewart Russell; Ryan Casey; Dung M Hoang; Benjamin W Little; Peter D Olmsted; David S Rumschitzki; Youssef Zaim Wadghiri; Edward A Fisher
Journal:  Anal Chem       Date:  2012-09-18       Impact factor: 6.986

Review 3.  Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.

Authors:  Michael A Bruckman; Xin Yu; Nicole F Steinmetz
Journal:  Nanotechnology       Date:  2013-10-24       Impact factor: 3.874

4.  Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.

Authors:  Dilip K Tosh; Khai Phan; Francesca Deflorian; Qiang Wei; Lena S Yoo; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2012-01-11       Impact factor: 4.774

Review 5.  Polyphosphorhydrazone-Based Radical Dendrimers.

Authors:  Vega Lloveras; José Vidal-Gancedo
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

6.  Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.

Authors:  Yuka Miyake; Syungo Ishikawa; Yu Kimura; Aoi Son; Hirohiko Imai; Tetsuya Matsuda; Hisatsugu Yamada; Akio Toshimitsu; Teruyuki Kondo
Journal:  Sensors (Basel)       Date:  2015-12-18       Impact factor: 3.576

Review 7.  A review of molecular imaging of atherosclerosis and the potential application of dendrimer in imaging of plaque.

Authors:  Gulinigaer Anwaier; Cong Chen; Yini Cao; Rong Qi
Journal:  Int J Nanomedicine       Date:  2017-10-19

8.  Magnetic hyperthermia of breast cancer cells and MRI relaxometry with dendrimer-coated iron-oxide nanoparticles.

Authors:  Marzieh Salimi; Saeed Sarkar; Reza Saber; Hamid Delavari; Ali Mohammad Alizadeh; Hendrik Thijmen Mulder
Journal:  Cancer Nanotechnol       Date:  2018-10-08

9.  Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.

Authors:  Marzieh Salimi; Saeed Sarkar; Samaneh Fathi; Ali Mohammad Alizadeh; Reza Saber; Fatemeh Moradi; Hamid Delavari
Journal:  Int J Nanomedicine       Date:  2018-03-13

Review 10.  Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.

Authors:  Weizhong Zhang; Lin Liu; Hongmin Chen; Kai Hu; Ian Delahunty; Shi Gao; Jin Xie
Journal:  Theranostics       Date:  2018-04-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.